James Homan - Taylor Wessing

James is a partner and corporate lawyer who specialises in advising on complex cross-border business transactions, including M&A, IPOs, joint ventures, structured equity investments, venture capital and growth capital financing rounds.

James acts for clients all the way through the life cycle, including founders, growth companies, VC investors, institutions and listed companies (both LSE and Nasdaq), primarily in the technology and structured investment sectors.

James joined Taylor Wessing as a trainee in 2010.

CV

Since 2023 Partner, Taylor Wessing

2017 - 2023 Senior Associate, Taylor Wessing

2012 - 2017 Associate, Taylor Wessing

Karriere

Since 2023 Partner, Taylor Wessing

2017 - 2023 Senior Associate, Taylor Wessing

2012 - 2017 Associate, Taylor Wessing

Ausbildung

2012 Admitted as a lawyer, England & Wales

2010 LPC distinction, BPP Law School

2008 LLB, University of Birmingham

Fremdsprachen

Experience

TSL Lombard

Advised on the sale of the business to Global Data plc.

Allocate Software

Advised Allocate Software plc on its £109 million recommended takeover by Hg Capital.

Pre-IPO funding rounds and IPOs

Various pre-IPO funding rounds and IPOs, including for FDM Group, Attraqt Group, Creo Medical, Sphere Medical, Rezolve, Tritax Big Box and Boku.

Tech funding rounds

Advising founders, companies and institutional investors on numerous venture and growth stage funding rounds, in the tech and life science sectors.

One.com

Advised Accel-KKR and the founders on the disposal of One.com to Cinven Private Equity.

Hilton Food Group

Hilton Food Group plc on its class 1 acquisition of Icelandic SeaChill, funded by a underwritten placing and senior debt package.

William Belcher

News & Insights: James Homan

Zu den Insights

Klicken Sie hier für Details

M&A / Gesellschaftsrecht und Kapitalmarktrecht

Advising Oxford Cancer Analytics on Series A funding

13. Januar 2025

von mehreren Autoren

M&A / Gesellschaftsrecht und Kapitalmarktrecht

Advising Rezolve AI on its listing on NASDAQ

23. August 2024

von Robert Fenner und James Homan

Klicken Sie hier für Details

Interface - The space race

The new space race – outlook and opportunities in 2024

James Homan and Timo Stellpflug look at the investment landscape for 'New Space' technologies.

2. Mai 2024

von James Homan und Timo Stellpflug

2 von 5 Insights

Klicken Sie hier für Details